SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 of 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) October 30, 1998
--------------------
SPECTRUM LABORATORIES. INC.
---------------------------
(Exact name of Registrant as specified in its charter)
California 0-9478 95-3557539
- ------------------------- --------------- -------------------
(State or other jurisdiction of (Commission File Number) (IRS Employer
incorporation or organization) Identification No.)
23022 La Cadena Drive, Laguna Hills, California 92653
- --------------------------------------------------------- -------------
(Address of principal executive offices) (Zip Code)
Registrants telephone number, including area code: (949) 581-3880
-------------------
Not Applicable
- ---------------------------------------------------
(Former name or former address, if changed since last report)
ITEM 2. ACQUISITION OR DISPOSITION OF ASSETS
The Company entered into a Reorganization Agreement with Spectrum Medical
Industries, Inc. ("SMI"), pursuant to which SMI was merged into the Company and
shareholders of SMI exchanged their shares at a rate of 98 shares of Spectrum
Laboratories, Inc. common stock for each share of SMI common stock. Shareholder
consent was required under California and Delaware law. No appraisal rights are
available to the Company's stockholders.
ITEM 7. FINANCIAL STATEMENTS, PRO FORMS FINANCIAL INFORMATION AND EXHIBITS.
A. FINANCIAL STATEMENTS OF BUSINESS ACQUIRED.
It is impracticable for the Company to provide the required financial
statements on the date this report is being filed. The Company intends to file
the required financial statements under cover of Form 8-K/A as soon as
practicable, but not later than 60 days after the date this report must have
been filed.
B. PRO FORMA FINANCIAL INFORMATION.
It is impracticable for the Company to provide the required pro forma
financial information on the date this report is being filed. The Company
intends to file the required financial statements under cover of Form 8-K/A as
soon as practicable, but no later than 60 days after the date this report must
have been filed.
SIGNATURES
----------
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
SPECTRUM LABORATORIES, INC.
Date: October 30, 1998 By: /s/ Roy T. Eddleman
---------------------------
Roy T. Eddleman
Chairman and Chief Executive Officer
-2-